'Funded till mid-2017'
Not sure where the CR school of thought is coming from.. wouldn't think it would be required till sometime in Q1 2017, if nothing were to happen between now and then.
Until then.. we have trial updates to look forward to.
Ann: Prima initiates Phase I melanoma study in Australia, page-22
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $465.4M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4167 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 17522 | 2 |
View Market Depth
| Last trade - 09.40am 15/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable